HomeCLGN • NASDAQ
Collplant Biotechnologies Ltd - ADR
add
$2.20
13.39%
After Hours:(4.09%)-0.090
$2.11
Closed: Jun 4, 7:53:08 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.06M | 1,996.94% |
Operating expense | 3.52M | -9.45% |
Net income | -1.45M | 65.39% |
Net profit margin | -70.66 | 98.35% |
Earnings per share | — | — |
EBITDA | -1.40M | 65.32% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.74M | -53.78% |
Total assets | 17.21M | -43.19% |
Total liabilities | 4.81M | -17.70% |
Total equity | 12.40M | — |
Shares outstanding | 11.45M | — |
Price to book | 2.35 | — |
Return on assets | -22.94% | — |
Return on capital | -25.92% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.45M | 65.39% |
Cash from operations | -1.17M | 64.13% |
Cash from investing | -8.00K | 90.24% |
Cash from financing | — | — |
Net change in cash | -1.17M | 65.96% |
Free cash flow | -1.08M | 43.93% |
Previous close
$2.54
Day range
$2.10 - $2.46
Year range
$1.55 - $5.48
Market cap
25.20M USD
Avg Volume
128.65K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2004
Website
Employees
57
